Home > Boards > US Listed > Biotechs > Assembly Biosciences, Inc. (ASMB)

ASMB axes ABI-H0731 program:

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
DewDiligence Member Profile
Member Level 
Followed By 751
Posts 115,534
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/7/2021 4:16:27 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/7/2021 4:09:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 4:48:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 4:42:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2021 4:40:05 PM
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 3/5/2021 5:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2021 4:01:10 PM
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of Triple Combination Therapy for the Treatment of... GlobeNewswire Inc. - 2/26/2021 7:30:00 AM
Assembly Biosciences EPS misses by $0.19, misses on revenue Seeking Alpha - 2/25/2021 4:33:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:13:42 PM
Assembly Biosciences scraps Phase 3 vebicorvir study plans Seeking Alpha - 2/25/2021 4:05:56 PM
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results and Recent Highlights GlobeNewswire Inc. - 2/25/2021 4:05:00 PM
Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies for Chronic Hepatitis B Virus Infec... GlobeNewswire Inc. - 2/25/2021 4:00:00 PM
Assembly Bio Announces Upcoming Investor Events GlobeNewswire Inc. - 2/19/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/17/2021 4:56:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/17/2021 3:08:23 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/16/2021 5:24:25 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/16/2021 4:26:19 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 7:04:27 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 6:50:55 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/10/2021 10:33:56 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/9/2021 1:02:25 PM
Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 2/5/2021 5:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/29/2021 6:03:35 AM
DewDiligence Member Level  Thursday, 02/25/21 04:27:08 PM
Re: DewDiligence post# 27
Post # of 34 
ASMB axes ABI-H0731 program:

https://finance.yahoo.com/news/assembly-biosciences-updates-pipeline-strategy-210000963.html
Quote:
Assembly Biosciences…today announced that it is foregoing its plans to initiate Phase 3 registrational studies of vebicorvir (VBR, or ABI-H0731) as a chronic suppressive therapy (CST) to concentrate its research and development efforts on finite and curative HBV therapies.

As part of this focused strategy on finite and curative HBV therapies, Assembly Bio will prioritize its portfolio of potent next generation core inhibitors and combinations of VBR with complementary mechanisms of action, and plans to rapidly advance multiple research programs focused on novel targets and new mechanisms to the clinic.

The company evidently agrees with my take on the program spelled out in #msg-159346890.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences